Table 1 lncRNAs differentially expressed in CAFs versus NOFs and the associated statistics. Positive fold change indicates upregulation in CAFs. lncRNA titles are extracted from Affymatrix U133 annotation file.
Symbol | LogFC | P-value | Adj p-val | Title |
|---|---|---|---|---|
ARHGEF26-AS1 | −1.209 | 1.82E-05 | 5.22E-04 | ARHGEF26 antisense RNA 1 (non-protein coding) |
CASC2 | −1.751 | 3.74E-12 | 1.86E-08 | cancer susceptibility candidate 2 (non-protein coding) |
DLEU2 | −1.539 | 1.51E-07 | 2.30E-05 | deleted in lymphocytic leukemia 2 (non-protein coding) |
FAM106A | −1.446 | 2.00E-05 | 5.54E-04 | family with sequence similarity 106, member A |
FLJ39739 | 1.297 | 1.12E-03 | 7.90E-03 | uncharacterized FLJ39739 |
FLJ22763 | −1.142 | 5.47E-08 | 1.16E-05 | uncharacterized LOC401081 |
FLJ42627 | −1.382 | 1.04E-04 | 1.63E-03 | uncharacterized LOC645644 |
FLJ45340 | −1.613 | 2.51E-05 | 6.43E-04 | uncharacterized LOC402483 |
GAS5 | 2.09 | 2.82E-05 | 6.96E-04 | growth arrest-specific 5 (non-protein coding) |
H19 | 2.377 | 5.95E-03 | 2.46E-02 | H19, imprinted maternally expressed transcript (non-protein coding) |
HCG18 | −1.826 | 1.44E-08 | 4.58E-06 | HLA complex group 18 (non-protein coding) |
HYMAI | −1.12 | 8.71E-05 | 1.46E-03 | hydatidiform mole associated and imprinted (non-protein coding) |
LINC00152 | 2.161 | 8.75E-05 | 1.46E-03 | long intergenic non-protein coding RNA 152 |
LINC00276 | −1.284 | 2.20E-10 | 2.93E-07 | long intergenic non-protein coding RNA 276 |
LINC00461 | −1.7 | 9.98E-08 | 1.75E-05 | long intergenic non-protein coding RNA 461 |
LINC00621 | 1.213 | 5.81E-03 | 2.41E-02 | long intergenic non-protein coding RNA 621 |
LOC100133669 | −1.028 | 4.89E-05 | 1.00E-03 | uncharacterized LOC100133669 |
LOC100190938 | −2.25 | 7.88E-06 | 2.96E-04 | uncharacterized LOC100190938 |
LOC100240734 | −1.019 | 5.13E-08 | 1.13E-05 | uncharacterized LOC100240734 |
LOC100272216 | −1.803 | 9.46E-04 | 7.07E-03 | uncharacterized LOC100272216 |
LOC100499466 | 1.22 | 1.71E-04 | 2.28E-03 | uncharacterized LOC100499466 |
LOC100506013 | 1.226 | 7.05E-03 | 2.76E-02 | uncharacterized LOC100506013 |
LOC100506710 | 1.367 | 2.21E-03 | 1.25E-02 | endogenous Bornavirus-like nucleoprotein 2 pseudogene |
LOC284454 | 1.16 | 2.00E-03 | 1.17E-02 | uncharacterized LOC284454 |
LOC285084 | −1.456 | 3.56E-06 | 1.78E-04 | uncharacterized LOC285084 |
LOC285696 | −1.413 | 2.94E-06 | 1.56E-04 | uncharacterized LOC285696 |
LOC339988 | −1.107 | 2.57E-03 | 1.39E-02 | uncharacterized LOC339988 |
LOC388692 | −1.048 | 1.87E-06 | 1.14E-04 | uncharacterized LOC388692 |
LOC389634 | −1.134 | 5.54E-07 | 5.04E-05 | uncharacterized LOC389634 |
LOC642852 | 1.011 | 1.69E-03 | 1.05E-02 | uncharacterized LOC642852 |
MALAT1 | 1.244 | 2.83E-02 | 7.40E-02 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
MEG3 | 1.09 | 3.66E-02 | 8.93E-02 | maternally expressed 3 (non-protein coding) |
MIR100HG | 1.347 | 5.28E-03 | 2.26E-02 | mir-100-let-7a-2 cluster host gene (non-protein coding) |
MIR22HG | 1.846 | 2.38E-04 | 2.85E-03 | MIR22 host gene (non-protein coding) |
NEAT1 | 1.297 | 4.94E-03 | 1.88E-02 | nuclear paraspeckle assembly transcript 1 (non-protein coding) |
PGM5-AS1 | −2.305 | 1.28E-06 | 8.91E-05 | PGM5 antisense RNA 1 (non-protein coding) |
TUG1 | 1.801 | 3.95E-04 | 3.98E-03 | taurine upregulated 1 (non-protein coding) |
XIST | 1.439 | 1.19E-03 | 7.32E-03 | X (inactive)-specific transcript (non-protein coding) |
ZNRD1-AS1 | −1.415 | 2.84E-09 | 1.48E-06 | ZNRD1 antisense RNA 1 (non-protein coding) |
